Cargando…
Inhibition of androgen receptor enhanced the anticancer effects of everolimus through targeting glucose transporter 12
Everolimus was designed as a mammalian target of rapamycin (mTOR) inhibitor. It has been proven as a targeted drug for gastric cancer (GC) therapy. However, long-term treatment with everolimus may cause severe side effects for recipients. Decreasing the dosage and attenuating the associated risks ar...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760431/ https://www.ncbi.nlm.nih.gov/pubmed/36594084 http://dx.doi.org/10.7150/ijbs.75106 |